A sugar that’s been linked to cancer could also serve as an early indicator of severe scleroderma, improving diagnosis and treatment options for patients with this rare disease.
Category: Research Highlight
GlycoNet Investigator Dr. Matthew Macauley is uncovering how carbohydrates influence immune cells in the brain and their impact on Alzheimer’s disease.
Travel Awards available for HQP(Trainees, Graduate Students, Postdoctoral Fellows & Research Associates)
GlycoNet Investigator’s discovery provides insight into a vital cellular process that could be leveraged to unlock new therapeutic pathways for neurodegenerative diseases and cancer.
New compounds could open more opportunities for vital medical treatments, organ and tissue transplants, and reproductive medicine.
GlycoNet scientists are expanding our knowledge of sugars to engineer new health solutions.
Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
It’s all about monitoring sugar – but not in the way you may think